Travere Therapeutics (TVTX) Other Gross PP&E Adjustments: 2015-2025
Historic Other Gross PP&E Adjustments for Travere Therapeutics (TVTX) over the last 7 years, with Sep 2025 value amounting to -$11.5 million.
- Travere Therapeutics' Other Gross PP&E Adjustments rose 26.80% to -$11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$52.9 million, marking a year-over-year increase of 28.68%. This contributed to the annual value of -$15.9 million for FY2024, which is 35.81% up from last year.
- Travere Therapeutics' Other Gross PP&E Adjustments amounted to -$11.5 million in Q3 2025, which was up 7.07% from -$12.3 million recorded in Q2 2025.
- In the past 5 years, Travere Therapeutics' Other Gross PP&E Adjustments ranged from a high of -$11.5 million in Q3 2025 and a low of -$29.7 million during Q4 2022.
- In the last 3 years, Travere Therapeutics' Other Gross PP&E Adjustments had a median value of -$16.5 million in 2024 and averaged -$16.9 million.
- Per our database at Business Quant, Travere Therapeutics' Other Gross PP&E Adjustments soared by 37.30% in 2021 and then decreased by 9.79% in 2022.
- Over the past 5 years, Travere Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at -$27.0 million in 2021, then fell by 9.79% to -$29.7 million in 2022, then rose by 16.66% to -$24.7 million in 2023, then soared by 35.81% to -$15.9 million in 2024, then grew by 26.80% to -$11.5 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$11.5 million for Q3 2025, versus -$12.3 million for Q2 2025 and -$13.2 million for Q1 2025.